Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Novo Nordisk A/S/ 6-K

SEC Filing · 6-K

Novo Nordisk A/S

SEC Filing

Filed Sep 21, 2026Accepted Sep 21, 2026, 11:11 AM EDTCIK 353278Accession 0001171843-26-006128
View company →Permanent SEC source ↗
Share

Company context

Current securities

NONOFOTC · EQUITY · CurrentNVONYSE · EQUITY · Current

Recent company filings

  1. 6-K filingSep 17, 2026
  2. 6-K filingSep 15, 2026
  3. 6-K filingSep 9, 2026
  4. 6-K filingAug 31, 2026
  5. 6-K filingAug 24, 2026

As-filed source

Primary evidence
As filedOpen full document ↗